Ravidasvir
Ravidasvir (PPI-668) is an orally active pan-genotypic NS5A inhibitor and antiviral agent. Ravidasvir exhibits antiviral activity against HCV genotypes 1 to 6, with EC50 values ranging from 0.04 to 1.14 nM. Ravidasvir shows no or extremely low activity against feline infectious peritonitis virus type II. Ravidasvir can be used in research related to hepatitis C virus infection.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1242087-93-9
- Formel: C42H50N8O6
- Molecular Weight:762.91
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Huh-7 | EC50 |
0.007 nM
Compound: 25
|
Antiviral activity against HCV genotype 1b Con1 infected in human HuH7 cells assessed as inhibition of viral RNA replication after 3 days by renilla luciferase reporter gene assay
Antiviral activity against HCV genotype 1b Con1 infected in human HuH7 cells assessed as inhibition of viral RNA replication after 3 days by renilla luciferase reporter gene assay
|
[PMID: 24320933] |
| Huh-7 | EC50 |
0.071 nM
Compound: 25
|
Antiviral activity against HCV genotype 1a H77 infected in human HuH7 cells assessed as inhibition of viral RNA replication after 3 days by renilla luciferase reporter gene assay
Antiviral activity against HCV genotype 1a H77 infected in human HuH7 cells assessed as inhibition of viral RNA replication after 3 days by renilla luciferase reporter gene assay
|
[PMID: 24320933] |
In Vitro
Ravidasvir potently inhibits HCV genotypes 1 to 6 with EC50 values of 0.04 to 1.14 nM[2].
Ravidasvir (10 μM; 72 h) exhibits absent-to-minimal anti-FIPV serotype II activity and causes cytotoxicity at 10 μM in CRFK cells[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | AUC0-24 | AUC0-∞ | Cmax | Tmax | T1/2 | MRT0-∞ | CL/F |
|---|---|---|---|---|---|---|---|---|---|
| Rat[1] | 35 mg/kg | p.o. | 811.25 ng·h/mL | 893.09 ng·h/mL | 132.35 ng/mL | 4.00 h | 3.24 h | 5.56 h | 0.0419 |
Chemical Information
-
CAS. Nr. 1242087-93-9
-
Molecular Weight 762.91
-
Formel C42H50N8O6
-
SMILES
C([C@@H](NC(OC)=O)C(C)C)(=O)N1[C@H](C=2NC=3C(N2)=CC=C(C3)C4=CC5=C(C=C4)C=C(C=C5)C=6NC(=NC6)[C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC7)CCC1
-
Synonyms
PPI-668
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Hefnawy M, et al. Validated Microwell-Based Spectrofluorimetric Method for Quantification of Ravidasvir (New Anti-Chronic Hepatitis C Virus-GT4) in Rat Plasma and Its Application to Pharmacokinetic Study. Drug Des Devel Ther. 2020;14:4377-4385. Published 2020 Oct 20. [Content Brief]
[2]. Wu G, et al. Pharmacokinetics, Safety, and Tolerability of Ravidasvir, with and without Danoprevir/Ritonavir, in Healthy Subjects. Antimicrob Agents Chemother. 2021;65(10):e0060021. [Content Brief]
[3]. Cook SE, et al. Investigation of monotherapy and combined anticoronaviral therapies against feline coronavirus serotype II in vitro. J Feline Med Surg. 2022;24(10):943-953. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Ravidasvir Related Classifications
HY-17619 Related Classifications
Powered by Bioz